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Two spectrophotometric methods are proposed for the
assay of oxcarbazepine (OXC) in bulk and dosage forms
using Folin-Ciocalteu phenol reagent (FCP) and 3-meth-
yl-2-benzothiazolinone hydrazine hydrochloride (MBTH)
as reagents. The first method involves addition of FCP
reagent to OXC in alkaline medium followed by measu-
rement of absorbance at 760 nm (method A), and the ot-
her involves addition of a fixed volume of MBTH after
treatment of OXC with ferric chloride and measurement
of absorbance at 456 nm (method B). In both methods, the
amount of chromogen formed corresponds to the amount
of OXC and the measured absorbance was found to in-
crease linearly with the concentration of OXC, which is
corroborated by the correlation coefficients of 0.9985 and
0.9984 for method A and B, respectively.
The systems obey Beer’s law for 5–30 g mL–1 and 10–50
g mL–1 for methods A and B, respectively. The apparent
molar absorptivity was calculated to be 8.06  103 L
mol–1 cm–1 and 3.126  103 L mol–1 cm–1 for methods A
and B, respectively. The limits of detection (LOD) and li-
mit of quantification (LOQ) were calculated to be 1.6 and
5 g mL–1 for method A and 3 and 10 g mL–1 for met-
hod B. The inter-day and intra-day imprecision of the
methods were found to be in the range of 1.1–1.7 and
0.9–1.1% for method A, and 1.1–1.9 and 0.6–0.9% for
method B. The accuracy ranged between 98.9–99.7% and
99.3– 100.1 for method A and B, respectively. No interfer-
ence was observed from common pharmaceutical excipi-
ents. The methods were successfully applied to the assay
of OXC in tablet preparations.
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Oxcarbazepine (OXC) 10,11-dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide
is a synthetic antiepileptic drug (1). It is used in the treatment of partial seizures in adults
and children. It is available as film coated tablets of different strengths – 150, 300 and
600 mg. A simple RP-HPLC method was reported for determining the plasma concen-
tration of OXC and its metabolites (2). Determination of OXC and its metabolites by the
LC-MS method (3) and a stability indicating RP-HPLC method for OXC were reported
(4). A square wave adsorptive stripping voltage method for pharmaceuticals containing
OXC (5), LC method for OXC and its metabolites from brain (6) and from cerebrospinal
fluid (7) were also reported. A spectrophotometric method based on the reaction of OXC
with potassium ferricyanide was reported (8), as well as HPLC method for the determi-
nation of OXC in pharmaceuticals (9). This paper reports two spectrophotometric proce-
dures involving the reaction of OXC with two reagents, that is, Folin-Ciocalteu phenol
reagent (FCP) and 3-methyl-2-benzothiazolinone hydrazine hydrochloride (MBTH).
EXPERIMENTAL
Apparatus
A Jasco model V-530 double beam UV-visible Spectrophotometer (Jasco, Japan) with
1 cm matched quartz cells was used for all absorbance measurements.
Reagents and standards
All chemicals used were of analytical purity grade and all solutions were prepared
in doubly distilled water.
Folin-Ciocalteu phenol reagent (FCP). – FCP reagent (2N, Sisco Research Laboratories
PVT Ltd, India), 1:2 with water, was prepared and used in method A.
3-Methyl-2-benzothiazolinone hydrazine hydrochloride (MBTH). – A 0.2% (m/V) solution
of MBTH (99%, Himedia Laboratories PVT Ltd, Mumbai, India) was prepared in water.
Standard solution of oxcarbazepine. – Pharmaceutical grade oxcarbazepine was procu-
red from Intas Pharmaceuticals (India). It was reported to be 99.97% pure and was used
as received. A stock solution of OXC was prepared in methanol (1 mg mL–1). 0.1 mg
mL–1 solution was used in methods A and B. Standard solutions were kept in refrigera-
tor till use.
Procedures
Method A. – Different aliquots (0.5 mL to 3 mL) of standard 0.1 mg mL–1 OXC solu-
tion were transferred into a series of 10-mL standard flasks. To each flask, 1 mL of FCP
(1:2) and 1 mL of sodium carbonate (20%, m/V) were added and kept aside for 15 min
under occasional shaking. The volume was then made up with water and absorbance of
each solution was measured at 760 nm.
Method B. – Varying aliquots (1 mL to 5 mL) of standard 0.1 mg mL–1 OXC solution
were transferred into a series of 10-mL standard flasks. To each flask, 1 mL of MBTH
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(0.2%, m/V) and 1 mL of ferric chloride (0.2%, m/V) were added and allowed to stand for
20 min under occasional shaking. The volume was then made up with water and absor-
bance of each solution was measured at 456 nm.
A standard graph was plotted in both methods and the unknown concentration was
read from the graph or computed from the regression equation derived using Beer’s law
data.
Procedure for tablets. – The formulation (Intas Pharmaceuticals, India) containing 150
mg/300 mg/600 mg was extracted with 3  20 mL of methanol individually. Combined
extract was filtered using Whatman filter paper and the volume was made up to 100 mL
with methanol. Further dilutions were made to get 1 mg mL–1 OXC. Five mL of this so-
lution was diluted to 50 mL with methanol. Appropriate volumes of this solution were
taken according to the procedures described earlier for methods A and B.
Validation of the method
Various concentrations of OXC were tested to fix the linearity range of the methods;
5–30 g mL–1 for method A and 10–50 g mL–1 for method B were selected based on the
correlation coefficient values (Table I). The limit of detection (LOD) and limit of quantifi-
cation (LOQ) were calculated according to the current ICH guidelines (10). LOD and
LOQ were calculated as 3.3 and 10 standard deviation of the blank (n = 6), respectively,
divided by the slope of the calibration line.
Accuracy of the method was evaluated by recovery studies using the standard addi-
tives method. To a fixed and known amount of the drug in tablet powder (pre analyzed
tablet containing 150 mg of OXC), pure OXC was added (50 and 100 mg) and the total
amount was found by the proposed methods, from which the percentage recovery of the
drug added was calculated.
Selectivity studies were performed separately by applying the proposed methods to
the determination of OXC in a synthetic mixture consisting of OXC, talc, starch, lactose,
calcium gluconate, calcium dihydrogen orthophosphate, sodium alginate and magnesium
stearate, in the mass ratio of 15:25:30:03:05:02:07:10. OXC was extracted with 3  20 mL
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Table I. Analytical and regression parameters of proposed methods
Parameter Method A Method B
lmax 760 456
Beer’s law limits (g mL–1) 5–30 10–50
Molar absorptivity (L mol–1 cm–1) 8.06  103 3.126  103
Limit of detection (g mL–1) 1.6 3
Limit of quantification (g mL–1) 5 10
Regression equationa
Intercept = a  SD






of methanol. Combined extract was filtered using Whatman filter paper and the volume
was made up to 100 mL with methanol and diluted to get 1 mg mL–1 OXC. It was further
diluted to get 0.1 mg mL–1 and the appropriate volume of this solution was taken accor-
ding to the procedures described in methods A and method B.
The inter-day and intra-day precision of the methods was tested on three concentra-
tions in the linear range, repeating each six times. The relative standard deviation was
determined. The confidence interval was also calculated.
RESULTS AND DISCUSSION
Method development
The proposed spectrophotometric methods are indirect and are based on determi-
nation of OXC after its reaction with either FCP or MBTH and measuring the chromogen
at the respective lmax.
OXC reduces FCP to give an intense blue color in method A. This is due to the re-
duction of 1, 2 and 3 oxygen atoms of FCP reagent and the formation of molybdenum
blue or tungsten blue. In method B, MBTH forms an electrophilic moiety while adding
ferric chloride, which in turn couples with OXC to give green chromogen. The probable
reaction of OXC with MBTH is represented in Fig. 1.
Preliminary experiments were conducted to determine the optimum concentration
and volumes of FCP and MBTH to give the highest response. A volume of 1 mL of FCP
(1:2) and 1 mL of 20% (m/V) sodium carbonate for method A and 1 mL of 0.2% (m/V) of
ferric chloride and 1 mL of 0.2% (m/V) of MBTH for method B were fixed.
The optimum time required for the reaction completion in two methods was the
studied and it was found that the reaction of OXC with FCP requires 15 min and OXC
that of with MBTH requires 20 min. The chromogen formed by both methods was stable
for not less than 2 hours.
The optical characteristics such as Beer’s law limits and molar absorptivity values,
together with other analytical performance characteristics such as LOD, LOQ, regression
equation parameters are given in Table I.
To evaluate intra-day and inter-day precision of the methods, pure OXC was ana-
lyzed at three different concentration levels, each determination being repeated six ti-
mes. The intra-day imprecision of OXC by two methods was between 0.9–1.1% for met-
hod A and 0.6–0.9% for method B. The RSD of both intra-day and inter-day were  1.9%
indicating good precision of the methods. Relative error ranged between 1.2 and 2.1%
for both methods.
The accuracy of the method was evaluated by recovery studies by adding pure OXC
to the pre-analyzed formulation. The average accuracy was found to be 99.3  0.3% for
method A and 99.7  0.7% for method B. The accuracy of the methods was compared
with the reference method (8) and is shown in Table II.
In the selectivity studies, OXC recovered was between 99.9 and 100% for method A
and 99.7 and 99.9% for method B from the synthetic mixture containing additives. This
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revealed that the additives had not interfered in the estimation of OXC by the two pro-
posed spectrophotometric methods.
Application of the methods to tablets
The spectrophotometric methods were applied successfully to tablets containing
OXC and the percent label claims were compared with those obtained by the reported
methods (5, 8). A comparison of the calibration range and % label claim between the cur-
rent methods and reference methods (5, 8) is shown in Table II.
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oxidative coupling species of
OXC-MBTH
Fig. 1. Probable reaction scheme.
CONCLUSIONS
Two rapid, sensitive and accurate colorimetric methods for the determination of
OXC have been developed and validated. They are rapid, do not involve complicated
extraction procedures or heating and consume less time. The current spectrophotometric
methods use cheap chemicals and inexpensive equipment while providing good sensiti-
vity comparable even to the HPLC. This makes the methods highly suitable for quick
routine analyses of OXC in pharmaceutical dosage forms.
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voltammetry
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S A @ E T A K
Upotreba Folin-Ciocalteuovog reagensa i 3-metil-2-benzotiazolinon hidrazin
hidroklorida u odre|ivanju okskarbazepina u ljekovitim pripravcima
MURUGANATHAN GANDHIMATHI i THENGUNGAL KOCHUPAPPY RAVI
Predlo`ene su dvije spektrofotometrijske metode za odre|ivanje okskarbazepina
(OXC) koje koriste Folin-Ciocalteu fenolni reagens (FCP) i 3-metil-2-benzotiazolinon
hidrazin hidroklorid (MBTH). Predlo`ene metode uspje{no su primijenjene za analizu
ljekovite tvari i ljekovitih pripravaka. Prva metoda uklju~uje adiciju FCP reagensa na
OXC u lu`natom mediju i mjerenje apsorbancije pri 760 nm (metoda A), a druga adiciju
istog volumena MBTH nakon obrade OXC sa `eljezovim(III) kloridom i mjerenje apsor-
bancije pri 456 nm (metoda B). U obje metode koli~ina stvorenog kromogena proporcio-
nalna je koli~ini OXC, a izmjerena apsorbancija linearno raste s koncentracijom OXC, uz
koeficijent korelacije 0,9985 i 0,9984 za metodu A odnosno B. Oba sustava podlije`u Bee-
rovom zakonu u koncentracijskom podru~ju 530 µg mL–1 i 10-50 g mL1 za metodu A
odnosno B. Izra~unati molni apsorpcijski koeficijent bio je 8,06  103 L mol1 cm1 za me-
todu A i 3,126  103 L mol1 cm–1 za metodu B. Granice detekcije (LOD) i granice kvanti-
fikacije (LOQ) bile su 1,6 i 5 g mL–1 za metodu A i 3 i 10 g mL–1 za metodu B. Nepre-
ciznost unutar dana i izme|u dana bila je 1,1-1,7 i 0,9-1,1% za metodu A, odnosno 1,1
1,9 i 0,6-0,9% za metodu B. Analiti~ki povrat bio je 98,999,7% za metodu A i 99,3-100,1
za metodu B. Nije primije}ena interferencija uobi~ajenih pomo}nih tvari. Metode su us-
pje{no upotrijebljene za odre|ivanje OXC u tabletama.
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